HB Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Sell |
33,939
-19
| -0.1% | -$2.11K | 0.03% | 256 |
|
|
2025
Q1 | $3.81M | Buy |
33,958
+7,547
| +29% | +$846K | 0.03% | 263 |
|
|
2024
Q4 | $2.44M | Buy |
26,411
+8,406
| +47% | +$776K | 0.02% | 250 |
|
|
2024
Q3 | $1.51M | Sell |
18,005
-380
| -2% | -$31.9K | 0.02% | 314 |
|
|
2024
Q2 | $1.26M | Buy |
18,385
+2,135
| +13% | +$146K | 0.01% | 324 |
|
|
2024
Q1 | $1.19M | Sell |
16,250
-2,333
| -13% | -$171K | 0.02% | 322 |
|
|
2023
Q4 | $1.51M | Buy |
18,583
+2,689
| +17% | +$218K | 0.02% | 267 |
|
|
2023
Q3 | $1.19M | Buy |
15,894
+4,222
| +36% | +$316K | 0.02% | 279 |
|
|
2023
Q2 | $900K | Buy |
11,672
+93
| +0.8% | +$7.17K | 0.01% | 305 |
|
|
2023
Q1 | $961K | Buy |
11,579
+572
| +5% | +$47.5K | 0.02% | 293 |
|
|
2022
Q4 | $945K | Buy |
11,007
+2,129
| +24% | +$183K | 0.02% | 292 |
|
|
2022
Q3 | $548K | Buy |
8,878
+1,666
| +23% | +$103K | 0.01% | 326 |
|
|
2022
Q2 | $446K | Buy |
7,212
+27
| +0.4% | +$1.67K | 0.01% | 365 |
|
|
2022
Q1 | $427K | Buy |
7,185
+3,316
| +86% | +$197K | 0.01% | 374 |
|
|
2021
Q4 | $281K | Buy |
+3,869
| New | +$281K | 0.01% | 400 |
|